What are the implications for clinical management and service development of prevalent comorbidity in UK mental health and substance misuse treatment populations?

Author： Weaver Tim   Stimson Gerry   Tyrer Peter   Barnes Thomas   Renton Adrian  

Publisher： Informa Healthcare

ISSN： 1465-3370

Source： Drugs: Education, Prevention & Policy, Vol.11, Iss.4, 2004-08, pp. : 329-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A case-linkage study of comorbidity in mental health and substance misuse care populations

By Keene Jan  

Drugs: Education, Prevention & Policy, Vol. 12, Iss. 4, 2005-08 ,pp. : 291-303

Informa Healthcare

Access to resources Recommend Favorite

Overview: Psychiatric Comorbidity and Substance Misuse: what are the issues?

By Crome Ilana B.  

Drugs: Education, Prevention & Policy, Vol. 6, Iss. 2, 1999-07 ,pp. : 149-150

Informa Healthcare

Access to resources Recommend Favorite

Substance Misuse and Psychiatric Comorbidity: towards improved service provision

By Crome Ilana B.  

Drugs: Education, Prevention & Policy, Vol. 6, Iss. 2, 1999-07 ,pp. : 151-174

Informa Healthcare

Access to resources Recommend Favorite

Understanding comorbidity? Australian service-user and provider perspectives on drug treatment and mental-health literacy

By Holt Martin   Treloar Carla  

Drugs: Education, Prevention & Policy, Vol. 15, Iss. 6, 2008-12 ,pp. : 518-531

Informa Healthcare

Access to resources Recommend Favorite

Self-harm and substance misuse in the UK—key issues for treatment and research

By Crome Ilana   Bloor Roger   Frisher Martin  

Drugs: Education, Prevention & Policy, Vol. 15, Iss. 2, 2008-04 ,pp. : 121-127

Informa Healthcare

Access to resources Recommend Favorite